TIL - Iovance Biotherapeutics prices $211M underwritten offering of common stock
2024-02-20 07:07:59 ET
More on Iovance Biotherapeutics
- Iovance: Approval For Historic Solid Tumor Targeting TIL Therapy Likely, Outlook Promising
- Iovance Biotherapeutics: Preparing For Volatility Around Lifileucel's Upcoming PDUFA Date
- Iovance Biotherapeutics: The Easiest Money May Have Been Made, But Approval Does Seem Likely
- Iovance gets FDA accelerated approval for advanced melanoma therapy (update)
- Iovance stock rebounds 15% as Mizuho weighs in FDA clinical hold